Loading...
Back to narrative

Agent Builder And Agentic Orchestration Will Expand Market Opportunities

Update shared on 10 Oct 2025

Fair value Increased 1.04%
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
5.7%
7D
-10.9%

UiPath’s analyst price target has been modestly increased from $13.30 to $13.44, as analysts cite ongoing product and partnership developments. However, they also note persistent competitive pressures in the automation market.

Analyst Commentary

Analysts have provided a balanced update on UiPath, highlighting both areas of optimism and ongoing caution as the company navigates industry trends and strategic initiatives.

Bullish Takeaways

  • Recent product launches and partnership announcements, especially updates to the Maestro orchestration platform, are viewed as positive steps that could support future growth.
  • UiPath continues to report strong customer engagement, with more than 450 customers now deploying agentic capabilities. This indicates meaningful traction for its automation solutions.
  • Net new annual recurring revenue outperformed some expectations. This reflects continued interest in UiPath's offerings even as the market evolves.

Bearish Takeaways

  • Despite investment in innovation, analysts note that competitive pressures in the automation space remain significant and may limit near-term valuation upside.
  • While customer wins are encouraging, it is still early to factor automation-driven growth into long-term forecasts. This suggests execution risk remains.
  • Ongoing market challenges mean that realized revenue improvements from new products and partnerships may take time to materialize.

What's in the News

  • UiPath recognized as a Leader in the Gartner Magic Quadrant for AI-Augmented Software Testing Tools, highlighting its advancements in AI-powered autonomous agents for quality assurance (Key Developments).
  • UiPath announced an expanded platform for agentic automation and orchestration, featuring new pre-built industry solutions, enhanced orchestration with Maestro, and advanced testing and governance capabilities. These features will be available September 30, 2025 (Key Developments).
  • UiPath launched a Conversational Agent with voice interaction enabled by Google’s Gemini models, allowing seamless integration of voice-driven AI agents into business processes (Key Developments).
  • UiPath announced new partnerships with OpenAI, NVIDIA, and Snowflake to integrate advanced AI models and data agents. These collaborations expand UiPath's capabilities in enterprise automation, orchestration, and process efficiency (Key Developments).
  • Earnings guidance for Q3 and full year fiscal 2026 issued, with expected quarterly revenue of $390M to $395M and annual revenue of $1.571B to $1.576B (Key Developments).

Valuation Changes

  • Consensus Analyst Price Target has risen slightly from $13.30 to $13.44, reflecting updated fair value estimates.
  • Discount Rate has increased modestly from 8.40% to 8.45%. This indicates a marginally higher perceived risk or return requirement.
  • Revenue Growth projections are virtually unchanged, holding near 8.72% year over year.
  • Net Profit Margin is stable, with a small increase from 4.65% to 4.65%.
  • Future P/E ratio has fallen from 94.00x to 91.67x. This suggests a slightly lower valuation relative to projected earnings.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.